Category: Otolaryngology

Aminoglycosides, potent antibiotics used worldwide, are a well-known cause of permanent hearing loss. The primary issue is ototoxicity, a damaging effect on the inner ear that reveals exactly what part of the ear do aminoglycosides affect and why the consequences can be so severe.

There is currently no single "gold standard" or **drug of choice for Ménière's disease** universally agreed upon, largely because evidence for many pharmacological interventions is very uncertain. Treatment focuses on managing specific symptoms like vertigo, hearing loss, and tinnitus with various medications and lifestyle modifications.

With an estimated 7.4% of the adult population experiencing vertigo at some point, many seek effective treatments beyond the commonly prescribed betahistine. For those wondering **what is better than betahistine**, a range of pharmacological alternatives, physical therapies, and lifestyle changes exist depending on the specific cause and individual patient needs.

Over 600,000 individuals in the U.S. are affected by Ménière's disease, yet there are currently no FDA-approved medications specifically for this condition. The investigational oral drug **SPI-1005**, containing the compound **ebselen**, is a frontrunner in late-stage clinical trials, offering renewed hope for patients suffering from fluctuating hearing loss and episodic vertigo.

Affecting over 50 million American adults, tinnitus is the perception of sound with no external source [1.4.1]. While many factors contribute to this condition, a key question for many is: **can supplements cause tinnitus**?

Over 100 million people in the United States experience allergic rhinitis annually, and many use nasal sprays like Flonase to manage their symptoms. A common concern for some users is the potential for ear issues like tinnitus, prompting the question: Can Flonase cause tinnitus? The answer is nuanced, as the medication is more likely to help allergy-related tinnitus rather than cause it.